Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000856415) titled 'Safety and efficacy of intravesical gentamicin for recurrent urinary tract infections and/ or catheter blockages' on Aug. 7.
Study Type: Interventional
Study Design:
Purpose: Prevention
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Safety/efficacy
Primary Sponsor: University of Calgary
Condition:
Urinary tract infection
Urinary tract infection
Infection - Studies of infection and infectious agents
Intervention:
Patient- or carer-administered 30mL of 0.48mg/mL gentamicin solution, intravesical, with solution retention in bladder for 60mins, o...